Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Crinetics Pharmaceuticals Inc buy Cantor Fitzgerald

Start price
€27.40
24.10.23 / 50%
Target price
€47.21
24.10.24
Performance (%)
53.28%
Price
€44.00
03.05.24
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Crinetics Pharmaceuticals Inc has seen massive gains of 53.28%. This prediction currently runs until 24.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Crinetics Pharmaceuticals Inc 11.111% 11.111%
iShares Core DAX® -0.922% -1.993%
iShares Nasdaq 100 0.371% -0.868%
iShares Nikkei 225® 2.224% -5.187%
iShares S&P 500 -0.026% -0.918%

Comments by Cantor_Fitzgerald for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 53.28%
Target price 47.210
Change
Ends at 24.10.24

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock, down previously from $52.00.
Ratings data for CRNX provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Crinetics Pharmaceuticals Inc

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€40.20
04.03.24
€59.82
04.03.25
9.45%
03.05.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€33.80
02.02.24
€46.28
02.02.25
30.18%
03.05.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€33.40
19.12.23
€45.55
19.12.24
31.74%
03.05.24

buy
Crinetics Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€30.60
04.12.23
€46.19
04.12.24
37.25%
03.05.24